Expert: Device makers should assess reimbursement early

01/27/2010 | Clinica (subscription required)

Medical-device makers should assess the potential reimbursement rates of products at the early stage of the development process, writes John Avellanet, Cerulean Associates' managing director. Evaluating the reimbursement implications early on could help companies to determine the profitability of a product before it reaches the market, Avellanet said.

View Full Article in:

Clinica (subscription required)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Paralegal
Mylan Inc.
Washington, DC
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director of Actuarial Services, Government Programs
PacificSource
Springfield, OR
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC